Ubs Group Ag Navidea Biopharmaceuticals, Inc. Transaction History

Ubs Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.07 - $0.12 $10,455 - $17,923	149,362 Added 59744.8%	149,612 $13,000
Q2 2023 Aug 11, 2023	BUY	$0.08 - $0.29 $12 - $43	150 Added 150.0%	250 $0
Q4 2022 Feb 08, 2023	SELL	$0.18 - $0.3 $0 - $1	-5 Reduced 4.76%	100 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $1.2 $6,671 - $11,119	-9,266 Reduced 98.88%	105 $0
Q4 2021 Feb 14, 2022	BUY	$1.0 - $1.82 $4,073 - $7,412	4,073 Added 76.88%	9,371 $9,000
Q3 2021 Nov 15, 2021	SELL	$1.53 - $1.85 $2,313 - $2,797	-1,512 Reduced 22.2%	5,298 $9,000
Q2 2021 Aug 13, 2021	BUY	$1.55 - $2.15 $6,392 - $8,866	4,124 Added 153.54%	6,810 $12,000
Q1 2021 May 12, 2021	BUY	$1.99 - $2.9 $3,721 - $5,423	1,870 Added 229.17%	2,686 $5,000
Q4 2020 Feb 11, 2021	SELL	$1.88 - $2.84 $1,821 - $2,751	-969 Reduced 54.29%	816 $2,000
Q3 2020 Nov 12, 2020	BUY	$2.69 - $4.95 $4,519 - $8,316	1,680 Added 1600.0%	1,785 $5,000
Q1 2020 May 01, 2020	BUY	$0.76 - $1.54 $76 - $154	100 Added 2000.0%	105 $0
Q4 2019 Feb 14, 2020	SELL	$0.65 - $1.26 $3,039 - $5,891	-4,676 Reduced 99.89%	5 $0
Q3 2019 Nov 14, 2019	BUY	$0.5 - $0.91 $2,288 - $4,164	4,576 Added 4358.1%	4,681 $3,000
Q2 2019 Aug 14, 2019	BUY	$0.62 - $3.6 $65 - $378	105 New	105 $0

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.